INDV (Indivior Pharmaceuticals, Inc. Common Stock) Stock Analysis - Analyst Ratings

Indivior Pharmaceuticals, Inc. Common Stock (INDV) is a publicly traded Healthcare sector company. As of May 20, 2026, INDV trades at $37.73 with a market cap of $4.32B and a P/E ratio of 22.16. INDV moved +2.42% today. Year to date, INDV is +3.53%; over the trailing twelve months it is +216.69%. Its 52-week range spans $7.33 to $41.00. Analyst consensus is strong buy with an average price target of $50.67. Rallies surfaces INDV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate INDV?

4 analysts cover INDV: 0 strong buy, 4 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $50.67.

INDV Key Metrics

Key financial metrics for INDV
MetricValue
Price$37.73
Market Cap$4.32B
P/E Ratio22.16
EPS$1.68
Dividend Yield0.00%
52-Week High$41.00
52-Week Low$7.33
Volume914.42K
Avg Volume0
Revenue (TTM)$1.24B
Net Income$210.00M
Gross Margin80.23%

INDV Analyst Consensus

4 analysts cover INDV: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $50.67.

Latest INDV News

Recent INDV Insider Trades

  • Ryan Barbara bought 8 (~$248.68) on Mar 13, 2026.
  • Ryan Barbara bought 31 (~$1.01K) on Mar 9, 2026.
  • Kingsley Stuart A bought 940 (~$29.95K) on Mar 6, 2026.

Common questions about INDV

What do analysts rate INDV?
4 analysts cover INDV: 0 strong buy, 4 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $50.67.
Does Rallies show INDV price targets?
Yes. Rallies tracks INDV analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is INDV research on Rallies investment advice?
No. Rallies provides research, data, and educational context for INDV. It does not provide personalized investment advice.
INDV

INDV